Pharmaceutical compositions and uses directed to lysosomal storage disorders
US11400067B2 · kind B2 · utility
0Cited by
0References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 11, 2017 |
| Grant date | Aug 2, 2022 |
| Priority date | — |
| Expiry date | Aug 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides for treating lysosomal storage disorders (LSDs) comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.